Continuity Biosciences Acquires Focal Medical

Full-Life Technologies Acquires Focus‑X Therapeutics

November 28, 2022

Biotechnology

Full‑Life Technologies, a global radiotherapeutics company, agreed to acquire New Jersey‑based Focus‑X Therapeutics to expand its peptide‑focused radiopharmaceutical pipeline. Focus‑X shareholders are eligible for an upfront payment plus up to $245 million in development, regulatory and sales milestones and royalties; the deal was expected to close in Q1 2023.

Fulgent Genetics Acquires Fulgent Pharma

November 7, 2022

Biotechnology

Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.

Cell Microsystems Acquires Fluxion Biosciences

August 23, 2023

Medical Devices

Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.

Spectrum Science Acquires Continuum Clinical

February 8, 2024

Healthcare Services

Spectrum Science has acquired Continuum Clinical from Blue Chip Worldwide to strengthen its clinical trial recruitment (CTR) capabilities. Continuum will merge into Spectrum’s CTR strategic pillar—bringing its MERIS technology, a large client roster, and leadership under Neil Weisman—creating a combined team of more than 130 clinical solutions specialists; financial terms were not disclosed.

Lennox Acquires Focus Scientific Solutions

February 1, 2022

Medical Devices

Lennox Holdings Ltd has acquired Focus Scientific Solutions, a Meath-based supplier of laboratory equipment and technical services, making Lennox the largest independent Irish company in the sector. The acquisition expands Lennox’s technical services capability and product portfolio to better serve biopharma and life sciences customers.

Veranex Acquires Fusion Biotec

December 13, 2022

Medical Devices

Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.